Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Metra, Norian form Orquest to commercialize Ultrafiber

Executive Summary

As a joint venture, Metra Biosystems Inc. and Norian Corp. have formed a new company, Orquest Inc., to commercialize a bone-graft substitute using Metra's osteogenic factors and Norian's biomimetic polymer Ultrafiber (mineralized collagen).
Deal Industry
  • Biotechnology
  • Medical Devices
  • Pharmaceuticals
  • Medical Devices
    • Biomaterials
Deal Status
  • Final
Deal Type
  • Alliance
    • Joint Venture
    • Marketing (Licensing)

Related Companies